Purpose: To study the corneal topographic response to IOP reduction in vernal keratoconjunctivitis (VKC) with steroidinduced glaucoma. Methods: A total of 42 eyes of 21 patients with VKC and steroid-induced glaucoma (Group I) and 66 eyes of 33 patients with VKC without glaucoma (Group II) underwent an evaluation by Orbscan topography. In eyes with glaucoma, the IOP was controlled medically and the corneal topography was repeated at 3 months to evaluate effect on corneal parameters. Results: The mean baseline IOP was 36.40713.08 mmHg in Group I, 14.6774.62 mmHg in Group II (Po0.0001). The IOP after treatment at 3 months follow-up was 15.0075.41 mmHg in Group I (Po0.0001). In Group I, the mean maximum Sim K decreased from 44.8673.21 D to 43.8772.62 D (P ¼ 0.031) and mean posterior corneal elevation decreased from 64.9722.36 lm to 35.7728.91 lm at 3 months after reduction of IOP (P ¼ 0.001). There was a significant positive correlation between the reduction in the IOP and the decrease in the posterior corneal elevation (r ¼ 0.664, P ¼ 0.001). Conclusion: Eyes with VKC with and without glaucoma have similar corneal topography. Increased IOP associated with steroid-induced glaucoma and VKC may contribute to an increase in the corneal curvature and posterior corneal elevation. These changes may be reversed by a reduction in the IOP with medical therapy.
Introduction
Vernal keratoconjunctivitis (VKC) is a seasonal or perennial allergic ocular surface disease that affects mainly young males aged 6-21 years. [1] [2] [3] [4] Many of these patients are treated with topical corticosteroids and can develop secondary open angle glaucoma. 5, 6 Visual morbidity due to this disease is considerable as the glaucoma leads to a gross diminution of vision before patients are aware of the problem.
Although corneal changes in VKC are well documented, [7] [8] [9] [10] [11] there has been no study on corneal changes in patients with steroidinduced glaucoma and VKC using a slit scan topography system. This study was designed to study the corneal topographic changes associated with steroid-induced glaucoma in eyes with VKC and the effect of reduction in intraocular pressure on the corneal variables.
Materials and methods
A prospective study of consecutive patients seen over 1 year, suffering from VKC was carried out. The study had been approved by our institutional review board and all participants gave informed consent in accordance with the Declaration of Helsinki.
Patients with VKC and a history of steroid usage, who had at least two of the following three criteria, were recruited for the study as Group IFapplanation intraocular pressure more than 21 mmHg on more than two occasions, glaucomatous optic nerve head changes or glaucomatous visual field defects on Humphrey 30-2 full threshold test. Those with VKC who did not meet these criteria were recruited as Group II. Patients with pre-existing glaucoma (prior to steroid use) or a history of ocular trauma or surgery were excluded from the study. A detailed history was taken for dose and duration of the steroid use, the reason for steroid use and any family history of glaucoma. Baseline examination included best-corrected visual acuity, slit lamp biomicroscopy, fundus examination, applanation tonometry, gonioscopy, Humphrey 30-2 full threshold perimetry, and Orbscan topography. In addition, 32 age matched healthy controls with a refractive error within71 D were taken for comparison.
The Orbscan II corneal topography system was used for the assessment of the corneal topography, anterior chamber depth, and pachymetry. The measurements were performed by one senior technician with more than 2 years experience with the Orbscan.
All steroids were stopped at presentation. Patients with an intraocular pressure of less than 40 mmHg were given acetazolamide for 3 days and simultaneously started on topical antiglaucoma treatment À0.2% brimonidine, 0.5% timolol, or 0.005% latanoprost. If the intraocular pressure was 440 mmHg at presentation, syrup glycerol was given in addition to maintain an intraocular pressure of less than 20 mmHg. During follow-up, some patients had an exacerbation of their VKC for which lotepred eye drops 0.5% were used sparingly.
Patients were reviewed at 2 weeks, 4 weeks, and 3 months. They were asked to stop systemic acetazolamide and/or glycerol 3 days prior to each visit to allow measurement of IOP on topical medications alone. During each visit Goldmann applanation tonometry, best-corrected visual acuity and fundus examinations were carried out. Corneal topography with Orbscan II was measured at the time of induction into the study and then 3 months after the IOP was controlled medically.
Patients who achieved their individualized target intraocular pressure, on medication, had their drug therapy tapered until the intraocular pressure were controlled without medication, and were then monitored till the end of the study.
Statistical analysis
Statistical Analysis was performed using descriptive statistics that is mean and standard deviation, for the continuous variables, whereas frequency distribution and percentages were calculated for categorical variables.
Astigmatism and its axis were calculated using double angle formula method. To look for significant differences at particular points of time for continuous variables, Student's t-test (unpaired) was applied. w 2 test was used to find associations between the categorical variables. Trend analyses within variables were assessed using two-way ANOVA for both the groups separately. A P-value of o0.05 has been considered statistically significant. SAS 8.0 statistical software has been used for these statistical analyses.
Results
A total of 42 eyes of 21 patients with VKC and steroidinduced glaucoma (Group I) and 66 eyes of 33 patients with VKC without glaucoma (Group II) and 32 eyes of 18 normal controls were included in the present study. There were 18 males and three females in Group I, 23 males and 10 females in Group II, and 10 males and eight females among the controls. The mean age of patients in Group I was 18.874.6 years (range 12-35 years) as compared to 11.775.1 years (range 4-22 years) in Group II (Po0.0001). The mean age of the controls was 18.273.3 years.
The mean duration of the disease was 5.072.73 year in Group I and 2.5672.21 year in Group II (Po0.0001). The mean baseline IOP was 36.40713.08 mmHg in Group I, 14.6774.62 mmHg in Group II (Po0.0001), and 15.273.82 mmHg in the controls. The IOP after treatment at 3 months follow-up was 15.0075.41 mmHg in Group I (Po0.0001). Historically topical dexamethasone (0.1%) was the most common type (78.5%) of steroid used followed by betamethasone (0.1%) in 16.6% and hydrocortisone ointment in 4.7% of cases in Group I, while fluoromethalone (0.1%) was the most commonly (63.6%) used steroid in Group II, followed by dexamethosone in 28.7% cases.
Mixed form of VKC was the most common form of VKC in Group I (22 eyes) followed by limbal (12 eyes) and palpebral (eight eyes) forms. Palpebral form (28 eyes) was the most common form in Group II followed by mixed (26 eyes) and limbal (12 eyes) forms.
Corneal parameters
The mean maximum Sim K was 43 Figure 1 . There was a significant difference between the inferior pachymetric values in the two groups (P ¼ 0.046) ( Table 1) .
Eight eyes (19.04%) in Group I and 11 eyes (15.15%) in Group II had suspicious clinical findings on corneal examination suggestive of keratoconus, which were then evaluated according to the Rabinowitz criteria. 10 The corneal curvature was measured at 3 mm from the centre at the 30, 60, 90, 120, and 1501 in the superior half of the topography and compared with corresponding points on the inferior half of the topography chart. The mean keratomery in the superior part of the cornea at 3 mm from the centre was 46.3370.89 D as compared to 47.3772.16 D in the inferior part of the cornea in Group I (P ¼ 0.03). In Group II, the mean keratometry in the superior part of the cornea at 3 mm from the centre was 48.9571.65 D as compared to 50.7375.12 D in the inferior part of the cornea (Po0.01). In both groups keratoconus was seen most commonly in the mixed form of VKC. (Figures 2 and 3 ). There was a significant positive correlation between the reduction in the IOP and the decrease in the posterior corneal elevation (r ¼ 0.664, P ¼ 0.001) ( Table 2) .
Discussion
Steroid-induced glaucoma is iatrogenic secondary open angle glaucoma, with decreased trabecular outflow causing a rise of intraocular pressure. In VKC steroidinduced glaucoma is a common complication as patients require long-term therapy and steroids are often used to provide early relief of symptoms. Bonini et al 1 in a long-term review of VKC recorded a 2% incidence of steroid-induced glaucoma.
Our study showed that the mixed form of VKC was most commonly associated with steroid-induced glaucoma, followed by the limbal, least with palpebral variety, while the palpebral form was the most common variety in VKC eyes without steroid-induced glaucoma. The palpebral form has been the most frequently reported form of VKC in previous studies. In a case series of 195 patients with long-term follow-up by Bonini et al, 1 the palpebral form (83.6%) of VKC was the most common followed by mixed form (8.7%) and limbal form (7.5%). In another study by Cameroon et al 8 out of 61 patients with VKC, there were 29 patients (47.54%) with palpebral form, 14 (22.95%) with limbal VKC and 18 (29.51%) with mixed form of vernal conjunctivitis.
A male preponderance was noted in patients of steroid-induced glaucoma in our study, this was seen both groups of patients having VKC which is consistent with previous studies on VKC. In a study by Neumann et al, 2 400 cases of VKC were reviewed in which 72.5% were males, while Khan et al 7 reported a male preponderance of 83.3% in 530 cases of VKC. The mean age distribution in our study, was 18.874.6 years in VKC with glaucoma and 11.775.1 years in VKC without glaucoma. Neumann et al 2 reported that 80% of cases with VKC were less than 15 years, while Khan et al 7 mentioned that 68.9% of cases were under 20 years. The three groups were not age and sex matched and this is one of the limitations of the present study which could have affected the results.
In our study, the maximum corneal power 43.8072.73 D in Group I and 44.0673.47 D in Group II (P ¼ 0.86) as compared to 42.7371.96 D in controls. In a study by Gortzak et al, 9 40 patients with vernal catarrh and 36 controls were studied and the maximum corneal power in vernal catarrh group was 44.975.1 D and in the control group it was 42.971.9 D.
In this study the incidence of keratoconus was 19% in steroid-induced glaucoma with VKC and 15% in VKC alone. In a study by Khan et al, 7 the incidence of keratoconus was 7%, while Totan et al 11 reported keratoconus in 26% of their cases. We found mixed form of VKC to be most commonly associated with keratoconus.
Until now there have been no reports of posterior corneal elevation in VKC patients. In our study, there was higher posterior corneal elevation in both VKC groups (64.9732.36 mm in Group I and 54.87722.66 mm . There was also a positive correlation between the IOP reduction and the change in the corneal elevation. This may indicate that in addition to an inherent corneal pathology which leads to corneal ectasia in VKC, in eyes with VKC and steroid-induced glaucoma, the IOP may play an additional role in producing corneal steepening and increasing the posterior corneal elevation. An increase in the IOP may accentuate the posterior corneal elevation and lead to an aggravation of the corneal ectasia. Hence, in addition to the permanent structural changes in the corneal stroma which produce corneal topographic changes in VKC with steroid-induced glaucoma, there may be an element of IOP related reversible change which can be reduced by controlling the IOP. The importance of posterior corneal elevation has been highlighted by Rao et al 12 who evaluated 60 eyes with suspicious videokeratography using Orbscan II. They reported that a posterior corneal elevation of 40 mm should be taken as the screening threshold for patients who want to undergo refractive surgery.
After reduction of the IOP there was a slight increase in the central corneal pachymetry from 524.17768.30 mm to 539.81766.82 mm in the present study. The increased IOP results in surface tension causing the globe including the cornea to expand with an increase in anterior/ posterior elevation and a decrease in thickness. 13 The high IOP may lead to a mechanical compression of corneal stromal lamellae and this may also contribute to an apparently lower pachymetric reading. With the reduction of the IOP, the corneal thickness is restored to normal levels and this may be responsible for the apparent increase in the central corneal pachymetry.
In conclusion, high IOP associated with steroidinduced glaucoma and VKC may lead to an increase in the corneal curvature, a significantly increased posterior corneal elevation and a reduction in the central corneal pachymetry and these changes may be reversed by a reduction in the IOP with medical therapy. Further long-term studies are required to study the effect of intraocular pressure on the corneal topography in VKC patients.
